Are there any cautions when taking perindopril (Coversyl) 8 mg and metoprolol 12.5 mg together in the morning with aspirin 81 mg, and taking lorazepam 1 mg, magnesium glycinate 200 mg, and acetaminophen (Tylenol) 1000 mg in the evening?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No Major Cautions with This Medication Regimen

Your current medication schedule—perindopril 8 mg, metoprolol 12.5 mg, and aspirin 81 mg in the morning, followed by lorazepam 1 mg, magnesium glycinate 200 mg, and acetaminophen 1000 mg in the evening—is generally safe with appropriate monitoring.

Key Drug Interactions and Monitoring Points

Morning Medications (Perindopril + Metoprolol + Aspirin)

Perindopril and Aspirin Combination:

  • This combination is commonly used and generally safe 1, 2
  • While older concerns existed about aspirin potentially reducing ACE inhibitor benefits, large meta-analyses have definitively shown that even when aspirin is given, adding ACE inhibitor therapy produces substantial additional cardiovascular benefit 3
  • The combination of low-dose aspirin (75-100 mg) with ACE inhibitors is actually recommended for patients with coronary disease, diabetes, or hypertension 2, 4
  • Your aspirin dose of 81 mg falls within the optimal range and is preferred over higher maintenance doses 1

Perindopril and Metoprolol Combination:

  • These drugs have complementary mechanisms and are frequently used together 5, 6
  • Both can lower blood pressure, so monitor for excessive blood pressure reduction (symptoms: dizziness, lightheadedness, fainting)
  • Both can slow heart rate—watch for heart rate below 50-55 bpm or symptoms of bradycardia (excessive fatigue, shortness of breath, dizziness)
  • This combination has been studied and shown effective for left ventricular hypertrophy regression 7

Perindopril Monitoring:

  • Check kidney function (creatinine) and potassium levels periodically 4
  • Watch for persistent dry cough (occurs in <2% but is the most common reason for discontinuation) 8
  • Avoid potassium supplements or salt substitutes containing potassium 5

Evening Medications (Lorazepam + Magnesium + Acetaminophen)

Lorazepam Cautions:

  • Most critical warning: Avoid alcohol completely while taking lorazepam—the combination can cause severe respiratory depression, coma, or death 9
  • Do not drive or operate machinery until you know how lorazepam affects you 9
  • Risk of dependence: Even at your dose (1 mg), physical dependence can develop with regular use 9
  • Never stop abruptly—if discontinuation is needed, requires gradual taper to prevent potentially life-threatening withdrawal seizures 9
  • Your dose of 1 mg is within the typical range (1-10 mg/day), but should be used for the shortest duration possible 9

Acetaminophen (Tylenol) at 1000 mg:

  • This is a safe single dose (maximum single dose is 1000 mg)
  • Critical warning: Do not exceed 3000-4000 mg total per day from all sources (including over-the-counter cold medications, which often contain acetaminophen)
  • No significant interactions with your other medications 3

Magnesium Glycinate 200 mg:

  • Generally safe and well-tolerated
  • No significant interactions with your other medications
  • May actually help with sleep and muscle relaxation

Timing Considerations

Your medication schedule is well-designed:

  • Morning medications: Cardiovascular drugs taken together is appropriate and allows for daytime blood pressure control
  • Evening medications: Separating lorazepam by approximately 12 hours from morning medications minimizes any additive sedative effects with metoprolol

Specific Monitoring Recommendations

Blood Pressure and Heart Rate:

  • Check blood pressure regularly at home (target <130/80 mmHg) 6
  • Monitor heart rate—report if consistently below 50-55 bpm
  • Watch for orthostatic hypotension (dizziness when standing up)

Signs Requiring Immediate Medical Attention:

  • Severe dizziness, fainting, or falls
  • Chest pain or shortness of breath
  • Swelling of face, lips, tongue, or throat (angioedema from perindopril)
  • Excessive drowsiness or difficulty breathing (especially if alcohol consumed)
  • Unusual bleeding or bruising

Laboratory Monitoring:

  • Kidney function (creatinine) and potassium levels every 6-12 months while on perindopril 4
  • More frequent monitoring if you have diabetes or existing kidney disease

Common Pitfalls to Avoid

  1. Do not take additional NSAIDs (ibuprofen, naproxen) regularly without discussing with your doctor—they can reduce the effectiveness of perindopril and increase kidney stress
  2. Avoid dehydration—ACE inhibitors can affect kidney function when dehydrated
  3. Do not double up on acetaminophen—check all over-the-counter medications for acetaminophen content
  4. Never share lorazepam with others—it's a controlled substance with abuse potential 9
  5. Do not stop metoprolol abruptly—requires gradual taper to avoid rebound hypertension or cardiac events 5

Drug-Specific Tolerability

Your low-dose metoprolol (12.5 mg) minimizes side effects while providing cardiovascular protection. Perindopril has a favorable safety profile with fewer first-dose hypotension events compared to other ACE inhibitors 8. The combination has been studied extensively and shows synergistic benefits for cardiovascular protection 10, 11, 12.

References

Research

Safety profile of perindopril.

The American journal of cardiology, 2001

Research

Perindopril/Indapamide/Amlodipine in Hypertension: A Profile of Its Use.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2022

Research

Perindopril/amlodipine (Prestalia(®)): a review in hypertension.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.